tebnow
Health Policy/KFF Health News/24m ago

Medicaid Contractors Set to Profit from New Eligibility Changes Under Trump’s Policy

Recent investigations reveal that states are investing heavily in contractors like Deloitte, Accenture, and Optum to comply with the One Big Beautiful Bill Act, a law that is expected to significantly reduce health and food benefits for millions of low-income individuals. These contractors are tasked with updating eligibility systems for Medicaid and the Supplemental Nutrition Assistance Program (SNAP), which have historically faced issues that can lead to eligible individuals losing their benefits. As states scramble to implement these changes, the financial implications are substantial, with millions allocated to contractors while potentially resulting in greater coverage losses for vulnerable populations. The Congressional Budget Office estimates that the Medicaid provisions of the new law could leave 7.5 million people uninsured by 2034, while approximately 2.4 million individuals may lose monthly food assistance. The law mandates that many states link Medicaid coverage to employment status, introducing additional barriers for low-income individuals to maintain their health insurance. The financial burden of these updates is significant, with states projected to spend at least $45.6 million collectively on system modifications, which are primarily funded by federal resources. Specific estimates highlight the costs associated with these changes: Wisconsin's Medicaid system updates are projected to cost nearly $6 million, while Iowa anticipates a minimum of $20 million in expenses. Other states, including Kentucky and Illinois, are also facing substantial costs as they adapt to the new requirements. As these changes roll out, starting with SNAP restrictions in 2025 and major Medicaid provisions later this year, the impact on low-income families and individuals could be profound, raising concerns about access to essential health services and food security.

Medicaid / SNAP / health policy / contractors / Trump administration

Disease & Epidemiology

Proposed $5 Billion Cut to NIH in 2027 Budget Faces Bipartisan Opposition

The White House has proposed a significant reduction of $5 billion to the National Institutes of Health (NIH) in its fiscal year 2027 budget request, which totals $41 billion. This budget plan includes a controversial proposal to reduce the number of NIH institutes and centers from 27 to 22, a move that is expected to face strong resistance from lawmakers across both parties. Key institutes targeted for elimination include the National Center for Complementary and Integrative Health, the Fogarty International Center, and the National Institute on Minority Health and Health Disparities. Additionally, the budget seeks to consolidate two institutes focused on drug and alcohol abuse into a new entity named the National Institute of Substance Use and Addiction Research. It also proposes relocating the National Institute of Environmental Health Sciences to the Centers for Disease Control and Prevention (CDC). The budget cuts extend to the Advanced Research Projects Agency for Health (ARPA-H), which is set to see its funding slashed from $1.5 billion to $945 million, potentially impacting innovative health research initiatives. These proposed changes are significant as they could hinder ongoing research efforts and limit the NIH's ability to address pressing health challenges. The NIH plays a crucial role in advancing medical research and public health, and such budget cuts could have far-reaching implications for healthcare professionals, researchers, and patients alike. As Congress prepares to review the budget, the likelihood of these proposals being enacted remains uncertain, with bipartisan pushback anticipated.

STAT News · 1h ago
Health Tech

VA Enhances Digital Services with AI and VR Technologies for Veterans' Care

The U.S. Department of Veterans Affairs (VA) has recently intensified its digital transformation initiatives to tackle longstanding operational challenges. Key advancements include the nationwide rollout of the Enterprise Scheduling System (EPS), which has significantly expedited community care appointment bookings for veterans. This system allows VA employees to efficiently schedule appointments with over 27,000 community care providers, enhancing access to care and reducing wait times. Previously, scheduling was cumbersome, with employees limited to booking only a few appointments daily. In addition to scheduling improvements, the Veterans Health Administration (VHA) has implemented an AI-driven platform from Salesforce across more than 150 facilities. This system integrates real-time data to streamline operations, reduce administrative burdens, and enhance decision-making processes. The AI identifies potential issues, such as long wait times or low patient satisfaction, and facilitates immediate responses by assembling relevant teams through a unified Slack communication system. Moreover, the VA is expanding its use of virtual reality (VR) therapy, partnering with Mynd Immersive to provide innovative treatment options for chronic pain and mental health issues. This therapy, which has shown promising results in clinical studies, will now be available at 45 additional centers, allowing veterans to manage their conditions from home. The VR program includes various therapeutic experiences aimed at reducing pain and anxiety, further supporting veterans' mental health. These technological advancements are crucial for improving the quality of care for veterans, ensuring they receive timely and effective treatment. As the VA continues to evolve its digital capabilities, it aims to connect even more community care providers to the EPS system, further enhancing veterans' access to healthcare services. The departure of Charles Worthington, the former CTO and CAIO, marks a significant transition as the VA navigates its ongoing digital transformation journey.

Healthcare IT News · 2h ago

Health Tech

All →

MUSC Health Enhances OR Efficiency with AI-Driven Analytics

MUSC Health, a prominent healthcare system in South Carolina, has adopted Apella's AI analytics technology to improve operating room (OR) scheduling and efficiency. The health system faced challenges due to increasing surgical demand and limited visibility into OR performance, relying heavily on manual EHR data that was often questioned for accuracy. To address these issues, MUSC Health implemented a real-time analytics platform that integrates with their existing EHR system, providing a more accurate and objective view of OR operations. The new system captures detailed timelines of surgical events and turnover processes without manual input, allowing staff to monitor real-time data and make informed decisions. Early involvement of surgeons and a structured rollout helped build trust and ensure smooth integration into daily workflows. Within weeks, the platform achieved 100% adoption among charge nurses, and its use quickly expanded to other perioperative teams. Significant improvements in data quality were observed, with Apella's timestamps proving six times more accurate than manual entries. The platform provided insights into inefficiencies, revealing that idle time between cleaning and setup was a major contributor to delays, rather than extended cleaning times as previously assumed. Additionally, the analytics highlighted scheduling inefficiencies, with 28% of cases underscheduled and 20% overscheduled, leading to wasted OR time. Moving forward, MUSC Health aims to leverage these insights to optimize surgical scheduling and enhance operational efficiency.

Healthcare IT News · 3h ago

Disease & Epidemiology

All →

White House Proposes 12% Budget Cut for Health Agencies in 2027

In a recent budget proposal for 2027, the White House has requested a significant reduction of over 12% in funding for the Department of Health and Human Services (HHS). This proposed budget mirrors the previous year's suggestions from the Trump administration, indicating a continued trend towards austerity in federal health spending. Key components of the proposal include substantial cuts to the National Institutes of Health (NIH) and the elimination of a health research agency, which could have far-reaching implications for medical research and public health initiatives. Additionally, the proposal introduces the establishment of a new agency focused on chronic diseases, named the Administration for a Healthy America. This agency aims to address the growing burden of chronic conditions, which affect millions of Americans and contribute significantly to healthcare costs. The budget serves as an agenda-setting document, outlining the administration's priorities for the upcoming year, although it is Congress that will ultimately determine the final appropriations. The proposed cuts raise concerns among healthcare professionals and researchers about the potential impact on public health programs and scientific research funding. As Congress deliberates on the budget, stakeholders in the healthcare sector will be closely monitoring the discussions to understand how these changes may affect their work and the health outcomes of the population. The outcome of this budget proposal could set the tone for health policy and funding for years to come.

STAT News · 3h ago

White House Proposes 12% Budget Cut for Health Agencies in 2027

The White House has proposed a significant budget cut of over 12% for the Department of Health and Human Services (HHS) in its 2027 federal budget request. This proposal mirrors previous budgetary suggestions made during the Trump administration and includes substantial reductions to the National Institutes of Health (NIH) and the elimination of a health research agency. Additionally, the budget outlines the establishment of a new agency focused on chronic diseases, named the Administration for a Healthy America. This budget proposal is crucial as it sets the tone for the administration's health priorities for the upcoming year, although it is Congress that will ultimately decide on the final appropriations. The proposed cuts could have far-reaching implications for health research funding and public health initiatives, potentially affecting a wide range of stakeholders, including researchers, healthcare providers, and patients. The NIH, a key player in medical research, may face challenges in funding ongoing and future studies, which could hinder advancements in various health fields. The creation of the new agency aims to address chronic diseases, which are a growing concern in the U.S., but the effectiveness of this initiative will depend on the overall budget allocation. As Congress reviews the proposal, healthcare professionals and organizations will be closely monitoring the developments to understand the potential impacts on health services and research funding.

STAT News · 3h ago

Industry Movements: Proxygen Appoints Chiara Conti as Chief Scientific Officer

In a notable shift within the pharmaceutical sector, Proxygen has announced the appointment of Chiara Conti as its new Chief Scientific Officer. Conti brings a wealth of experience from her previous role as Senior Director at Blueprint Medicines, where she contributed significantly to the company's research and development efforts. This strategic hire reflects Proxygen's commitment to advancing its scientific initiatives and enhancing its leadership team. The pharmaceutical industry is continuously evolving, and such appointments are crucial for fostering innovation and driving growth. As companies seek to fill key positions, the movement of talent can have a substantial impact on their operational capabilities and future success. Stakeholders and industry professionals are keenly observing these changes, as they often signal shifts in research focus and corporate strategy.

STAT News · 5h ago

Pharma & Medications

All →

FDA Approves Foundayo: First New Molecular Entity Under National Priority Voucher Program

The U.S. Food and Drug Administration (FDA) has approved Foundayo (orforglipron), marking a significant milestone as the first new molecular entity (NME) approved under the National Priority Voucher (CNPV) pilot program. This approval, which occurred just 50 days after the application was filed, is the fastest for an NME since 2002. Foundayo is indicated for adults with obesity or overweight who have at least one weight-related comorbidity, and is intended to be used alongside a reduced-calorie diet and increased physical activity to aid in weight loss and maintenance. The CNPV program, launched in 2025, aims to expedite the approval process for drugs that address critical national health priorities. The FDA has issued 18 vouchers and made six decisions under this program, which emphasizes enhanced communication and rolling reviews to shorten approval times without compromising safety. The target timeline for decisions is two months, reflecting the FDA's commitment to efficiency and thoroughness in drug evaluation. Foundayo is a glucagon-like peptide-1 (GLP-1) receptor agonist available in tablet form, with a starting dosage of 0.8 mg, which can be increased based on patient response. Clinical trials demonstrated that treatment with Foundayo, in conjunction with lifestyle changes, led to significant weight loss compared to placebo. However, the drug is associated with potential side effects, including gastrointestinal issues and warnings for serious conditions such as pancreatitis and thyroid tumors. The FDA plans to hold a public meeting on June 4, 2026, to gather feedback on the CNPV program, including its eligibility criteria and review processes. This meeting aims to refine the program and ensure it continues to meet the needs of patients and healthcare providers effectively. Eli Lilly and Company received the approval for Foundayo, providing a new option for individuals struggling with obesity and related health issues.

FDA News · 2d ago

Clinical Research

All →

Osteochondroma Identified as Rare Cause of Recurrent DVT and PE in Young Athlete

A recent clinical case highlights an unusual etiology of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE) in a young athlete, attributed to an osteochondroma compressing the popliteal vein. This case underscores the importance of considering anatomical abnormalities in patients presenting with unexplained thrombotic events, particularly in younger populations who may not exhibit typical risk factors. The athlete, previously healthy, experienced multiple episodes of DVT and PE, prompting further investigation that revealed the presence of an osteochondroma. This benign bone tumor, while rare, can lead to significant vascular complications when located near major veins. The identification of such conditions is crucial for timely intervention, which may include surgical resection of the tumor to alleviate vascular compression and prevent future thrombotic events. This case serves as a reminder for healthcare professionals to maintain a broad differential diagnosis when evaluating young patients with recurrent thromboembolic events.

The Lancet

Health Policy

All →

Tax Implications of ACA Subsidies: What Enrollees Need to Know for 2026

As tax season approaches, many individuals enrolled in Affordable Care Act (ACA) plans are facing unexpected financial consequences due to premium subsidies received in the previous year. The ACA subsidies are designed to help lower-income individuals afford health insurance by capping their premium contributions based on a sliding scale of household income. However, enrollees must reconcile their estimated income with their actual earnings when filing taxes, which can lead to owing money back if their income exceeds projections. This year, over 90% of ACA enrollees received some form of subsidy, making accurate income estimation crucial. For the 2025 tax year, individuals earning less than $31,300 face a repayment cap of $375, while those with higher incomes could owe significantly more, with caps reaching $1,625 for individuals earning up to $50,000. However, the repayment caps will be eliminated for the 2026 tax year, meaning individuals whose income exceeds their projections could face substantial financial burdens. This change is part of the One Big Beautiful Bill Act, which has raised concerns among tax assistance organizations about the potential impact on low-income families. Additionally, the expiration of enhanced tax credits from the COVID-19 era has increased the percentage of income that households must contribute toward premiums, further complicating financial planning for ACA enrollees. Many individuals are now considering working additional hours to cover rising costs, which could inadvertently reduce their subsidy eligibility. Experts urge enrollees to update their income projections regularly to avoid unexpected tax liabilities. As the landscape of ACA subsidies continues to evolve, understanding these changes is essential for maintaining affordable healthcare coverage.

KFF Health News · 8h ago

Federal Judge Blocks Vaccine Recommendation Changes, Leaving Parents and Clinicians in Uncertainty

A recent ruling by a federal judge has halted the Trump administration's attempt to reduce the list of recommended childhood vaccines. This decision, which affects the Health and Human Services Secretary's new guidelines, has raised significant concerns among parents and healthcare providers regarding the implications for public health. The judge's ruling comes at a time when vaccine-preventable diseases, including measles, mumps, and whooping cough, are on the rise across the United States, particularly in the Washington, D.C. area. The ongoing legal battle is expected to create further confusion as the Trump administration is likely to appeal the ruling, leaving the future of vaccine recommendations uncertain. This situation highlights the challenges faced by public health officials in maintaining consistent vaccination policies amid shifting political landscapes. The fluctuating guidelines could impact vaccination rates and public health outcomes, particularly for vulnerable populations such as children. Healthcare professionals are urged to stay informed about the evolving vaccine recommendations and to communicate effectively with parents about the importance of vaccinations in preventing outbreaks of infectious diseases. As the situation develops, it will be crucial for public health agencies to provide clear guidance to mitigate confusion and ensure that children receive the necessary vaccinations to protect their health.

KFF Health News · 9h ago